Literature DB >> 34039936

Review of Genotype-Phenotype Correlations in Usher Syndrome.

Eric Nisenbaum1,2, Torin P Thielhelm1,2, Aida Nourbakhsh1, Denise Yan1, Susan H Blanton1,3, Yilai Shu4, Karl R Koehler5, Aziz El-Amraoui6, Zhengyi Chen7, Byron L Lam8, Xuezhong Liu1,3.   

Abstract

Usher syndrome (USH) encompasses a group of clinically and genetically heterogenous disorders defined by the triad of sensorineural hearing loss (SNHL), vestibular dysfunction, and vision loss. USH is the most common cause of deaf blindness. USH is divided clinically into three subtypes-USH1, USH2, and USH3-based on symptom severity, progression, and age of onset. The underlying genetics of these USH forms are, however, significantly more complex, with over a dozen genes linked to the three primary clinical subtypes and other atypical USH phenotypes. Several of these genes are associated with other deaf-blindness syndromes that share significant clinical overlap with USH, pointing to the limits of a clinically based classification system. The genotype-phenotype relationships among USH forms also may vary significantly based on the location and type of mutation in the gene of interest. Understanding these genotype-phenotype relationships and associated natural disease histories is necessary for the successful development and application of gene-based therapies and precision medicine approaches to USH. Currently, the state of knowledge varies widely depending on the gene of interest. Recent studies utilizing next-generation sequencing technology have expanded the list of known pathogenic mutations in USH genes, identified new genes associated with USH-like phenotypes, and proposed algorithms to predict the phenotypic effects of specific categories of allelic variants. Further work is required to validate USH gene causality, and better define USH genotype-phenotype relationships and disease natural histories-particularly for rare mutations-to lay the groundwork for the future of USH treatment.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34039936      PMCID: PMC8613301          DOI: 10.1097/AUD.0000000000001066

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.562


  100 in total

1.  A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.

Authors:  Inga Ebermann; Hendrik P N Scholl; Peter Charbel Issa; Elvir Becirovic; Jürgen Lamprecht; Bernhard Jurklies; José M Millán; Elena Aller; Diana Mitter; Hanno Bolz
Journal:  Hum Genet       Date:  2006-12-15       Impact factor: 4.132

2.  Novel ABHD12 mutations in PHARC patients: the differential diagnosis of deaf-blindness.

Authors:  Hidekane Yoshimura; Takao Hashimoto; Toshinori Murata; Kunihiro Fukushima; Akiko Sugaya; Shin-Ya Nishio; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-05       Impact factor: 1.547

3.  Is it Usher syndrome? Collaborative diagnosis and molecular genetics of patients with visual impairment and hearing loss.

Authors:  Heather A Stiff; Christina M Sloan-Heggen; Ashley Ko; Wanda L Pfeifer; Diana L Kolbe; Carla J Nishimura; Kathy L Frees; Kevin T Booth; Donghong Wang; Amy E Weaver; Hela Azaiez; John Kamholz; Richard J H Smith; Arlene V Drack
Journal:  Ophthalmic Genet       Date:  2020-04-13       Impact factor: 1.803

4.  Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss.

Authors:  Jun Yang; Xiaoqing Liu; Yun Zhao; Michael Adamian; Basil Pawlyk; Xun Sun; D Randy McMillan; M Charles Liberman; Tiansen Li
Journal:  PLoS Genet       Date:  2010-05-20       Impact factor: 5.917

5.  Mutation profile of the CDH23 gene in 56 probands with Usher syndrome type I.

Authors:  A Oshima; T Jaijo; E Aller; J M Millan; C Carney; S Usami; C Moller; W J Kimberling
Journal:  Hum Mutat       Date:  2008-06       Impact factor: 4.878

6.  Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.

Authors:  Nicolas Michalski; Vincent Michel; Amel Bahloul; Gaëlle Lefèvre; Jérémie Barral; Hideshi Yagi; Sébastien Chardenoux; Dominique Weil; Pascal Martin; Jean-Pierre Hardelin; Makoto Sato; Christine Petit
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

7.  Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II.

Authors:  Michael D Weston; Mirjam W J Luijendijk; Kurt D Humphrey; Claes Möller; William J Kimberling
Journal:  Am J Hum Genet       Date:  2004-01-20       Impact factor: 11.025

8.  Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3.

Authors:  Tobias Eisenberger; Rima Slim; Ahmad Mansour; Markus Nauck; Gudrun Nürnberg; Peter Nürnberg; Christian Decker; Claudia Dafinger; Inga Ebermann; Carsten Bergmann; Hanno Jörn Bolz
Journal:  Orphanet J Rare Dis       Date:  2012-09-02       Impact factor: 4.123

9.  Life strategies of people with deafblindness due to Usher syndrome type 2a - a qualitative study.

Authors:  Mattias Ehn; Agneta Anderzén-Carlsson; Claes Möller; Moa Wahlqvist
Journal:  Int J Qual Stud Health Well-being       Date:  2019-12

10.  Identification of five novel mutations in the long isoform of the USH2A gene in Chinese families with Usher syndrome type II.

Authors:  Hanjun Dai; Xiaohui Zhang; Xin Zhao; Ting Deng; Bing Dong; Jingzhao Wang; Yang Li
Journal:  Mol Vis       Date:  2008-11-17       Impact factor: 2.367

View more
  3 in total

Review 1.  Usher Syndrome.

Authors:  Alessandro Castiglione; Claes Möller
Journal:  Audiol Res       Date:  2022-01-11

Review 2.  The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification.

Authors:  Sedigheh Delmaghani; Aziz El-Amraoui
Journal:  Hum Genet       Date:  2022-03-30       Impact factor: 5.881

3.  Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.

Authors:  Hannie Kremer; Cornelis P Lanting; Markus Damme; Hedwig M Velde; Janine Reurink; Sebastian Held; Catherina H Z Li; Suzanne Yzer; Jaap Oostrik; Jack Weeda; Lonneke Haer-Wigman; Helger G Yntema; Susanne Roosing; Laurenz Pauleikhoff; Clemens Lange; Laura Whelan; Adrian Dockery; Julia Zhu; David J Keegan; G Jane Farrar; Ronald J E Pennings
Journal:  Hum Genet       Date:  2022-02-28       Impact factor: 5.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.